1.
Vopr Onkol
; 58(5): 663-6, 2012.
Article
in Russian
| MEDLINE
| ID: mdl-23600285
ABSTRACT
The effect of dicarbamine on hemopoiesis in experimental post-irradiation bone-marrow syndrome was studied. The myeloprotective activity of the drug was established. It manifested in the protection of hematopoietic progenitor cells and stimulation of cell proliferation and differentiation in the bone marrow.